Histone H3 lysine 79 (H3K79) methylation is enriched on actively transcribed genes, and its misregulation is a hallmark of leukemia. Methylation of H3K79, which resides on the structured disk face of the nucleosome, is mediated by the Dot1L methyltransferase.
Introduction
Histone lysine methylation contributes to the regulation of transcription by tuning the recruitment of effector proteins to specific genomic sites (Hyun et al., 2017) . It exists in mono-, di-, and trimethylated (me1, me2, and me3) forms, and functional outcomes depend on both the methylated histone residue and degree of methylation (Greer and Shi, 2012) . Most well-characterized sites of histone lysine methylation are found in the flexible N-terminal tails of histones (Zhao and Garcia, 2015) . One counterexample is histone H3 Lys79 (H3K79), which is solvent exposed on the structured disk face of the nucleosome (Luger et al., 1997) . H3K79 methylation is observed within transcriptionally active genes, and methylation levels are highly correlated with gene expression (Schübeler et al., 2004; Wang et al., 2008; Wood et al., 2018) . In human cells, H3K79me2/me3 are enriched immediately after transcription start sites and decrease gradually across gene bodies, while H3K79me1 is distributed more broadly across the bodies of active genes (Wang et al., 2008) . Dot1L/KMT4 (disruptor of telomeric silencing-1 like/lysine methyltransferase 4) is the primary H3K79 methyltransferase in human cells and is conserved across eukaryotes (Feng et al., 2002; Lacoste et al., 2002; Ng et al., 2002a; van Leeuwen et al., 2002) . Rather than having the characteristic SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain found in other histone lysine methyltransferases (Dillon et al., 2005) , Dot1 proteins have a catalytic domain resembling class I methyltransferase domains found in DNA and protein arginine methyltransferases (Min et al., 2003; Sawada et al., 2004) . While known to participate in several transcriptional elongation complexes (Wood et al., 2018) , Dot1L can bind to and methylate H3K79 in nucleosomes in isolation (Feng et al., 2002; Min et al., 2003) . Histone H3 alone is a poor substrate for Dot1L, suggesting that Dot1L requires non-H3 surfaces of the nucleosome for substrate binding and/or activity (Feng et al., 2002; Lacoste et al., 2002; Ng et al., 2002a) .
Efficient methylation of H3K79 in cells requires prior ubiquitylation of H2BK120 (Briggs et al., 2002; Kim et al., 2005; Ng et al., 2002b) . H3K79me2/me3 are significantly decreased without change to H3K79me1 following knockdown of the H2BK120targeting ubiquitin E3 ligase, Bre1, in human cells or upon mutation of H2BK120 in S.
cerevisiae (Kim et al., 2005; Shahbazian et al., 2005) . Using designer nucleosomes assembled with monoubiquitylated H2BK120 (H2BK120ub), this trans-histone crosstalk between H2BK120ub and H3K79 methylation has been shown to be direct and require only the catalytic domain of Dot1L (McGinty et al., 2008) . Previous studies implicate the C-terminal tail of ubiquitin and the N-terminal tail of histone H2A in mediating ubiquitin-dependent Dot1L activity (Holt et al., 2015; Zhou et al., 2016) . The N-terminal tail of H4 has also been shown to be important for Dot1L activity independent of H2B ubiquitylation (Fingerman et al., 2007; McGinty et al., 2009) . In recent years, Dot1L has emerged as a potential therapeutic target for MLL-rearranged leukemias because the catalytic activity of Dot1L is required for leukemogenic transformation following MLLfusion translocations (Bernt et al., 2011; Winters and Bernt, 2017 ). Yet, key molecular details describing how Dot1L binds to the nucleosome and is activated by H2B ubiquitylation remain elusive.
Here we report the 3.9 Å cryo-EM structure of the methyltransferase domain of human Dot1L bound to a designer nucleosome core particle assembled with a sitespecifically modified H2BK120ub ( Figure 1A) . The structure captures Dot1L in a poised state in which Dot1L uses an arginine to anchor to the acidic patch on the nucleosome and is clamped in place by ubiquitin. In the structure, the catalytic site of Dot1L is separated from H3K79, indicating that Dot1L and/or the nucleosome must undergo conformational rearrangement from a poised to an active state for methylation.
Results

Cryo-EM structure of Dot1L bound to H2BK120ub nucleosome
In order to visualize the molecular details of Dot1L function on nucleosomes and activation by H2BK120 ubiquitylation, we first needed to prepare homogeneously sitespecifically ubiquitylated nucleosomes. To this end, we generated and purified an H2BK120ub analog by crosslinking ubiquitin with a Gly76Cys mutation at its terminal residue to an H2BK120C mutant using dichloroacetone (DCA) as previously described ( Figure S1 ) . Importantly, we observe slightly increased Dot1L methyltransferase activity when using nucleosomes reconstituted with two copies of this purified DCA-crosslinked analog as compared to nucleosomes assembled with two copies of a more precise semisynthetic analog of H2BK120ub containing a single Gly76Ala point mutation in ubiquitin (McGinty et al., 2009) . As this Gly76Ala analog was previously established to be indistinguishable from natively linked H2BK120ub in a Dot1L methyltransferase assay, we can extrapolate that Dot1L is activated by our DCAcrosslinked analog similarly to, if not to a greater extent than native H2BK120ub. We reconstituted our homogeneous DCA-crosslinked H2BK120ub nucleosome core particles with a minimal catalytic fragment of Dot1L (Dot1L cat ) ( Figure S1 ). This fragment spanning amino acids 2-416 includes the catalytic domain of Dot1L and an adjacent lysine-rich sequence that was previously identified to be necessary and sufficient for nucleosome binding and activity ( Figure 1B) (Min et al., 2003) . Although stable in solution, Dot1L cat dissociated from H2BK120ub nucleosomes during cryo-EM sample preparation under all conditions tested. To improve complex stability, we crosslinked the complex with glutaraldehyde prior to vitrification. This allowed for visualization of a Dot1L cat -H2BK120ub nucleosome complex by cryo-EM.
We initially resolved a 1:1 Dot1L cat -H2BK120ub nucleosome complex from 3D reconstruction of ~100,000 particles at 3.5 Å resolution ( Figure S2 , Classes 3 and 4). In this reconstruction, high resolution features in the nucleosome region of the density map are consistent with the estimated resolution. However, conformational heterogeneity in Dot1L and ubiquitin limit resolution in their respective regions of the reconstructed map.
To improve Dot1L and ubiquitin visualization, we reclassified the particles used for the 3.5 Å reconstruction into four subclasses, leading to the identification of two major conformational states (Classes 2A and 4A). We used Class 2A to generate a 3.9 Å reconstruction, that while having a lower overall resolution than our initial map, has improved density for Dot1L and ubiquitin generally, and does not compromise high resolution information at the Dot1L-nucleosome interface. The observed conformational heterogeneity in Dot1L and ubiquitin is further illustrated by finer classification into 10 subclasses, where a continuum of Dot1L and ubiquitin conformations is observed (Classes 5B, 9B, and 10B) ( Figure 1C ). As these classes did not have sufficient particles to allow for high resolution reconstruction, subsequent modeling was completed using the 3.9 Å map. It is worth noting that we anticipated a 2:1 complex (i.e. two copies of Dot1L per ubiquitylated nucleosome) due to the expected ability of the methyltransferase to bind to each face of the psuedosymmetric nucleosome core particle (McGinty et al., 2009; Zhou et al., 2016) . However, we initially observed only sparse density in the regions corresponding to Dot1L and ubiquitin on one nucleosome face. This is likely due to loss of Dot1L on the other nucleosome face during sample freezing and the resulting conformational heterogeneity of ubiquitin when unconstrained by Dot1L. This is consistent with a previous crystal structure of an unbound H2BK120ub nucleosome that lacks defined density for ubiquitin (Machida et al., 2016) . Only in the finer classification described above did we identify minor class averages with definitive density for a 2:1 Dot1L:nucleosome complex (Class 4B) or density for ubiquitylated nucleosomes only (Class 7B), demonstrating that despite crosslinking with glutaraldehyde our particles include an ensemble of Dot1L:nucleosome stoichiometries.
With the optimal 3.9 Å resolution reconstructed map in hand, we generated a Dot1L cat -H2BK120ub nucleosome model by docking high resolution crystal structures of the nucleosome core particle, one Dot1L catalytic domain, and one ubiquitin into the map followed by iterative manual model building and real-space refinement ( Figure 1A ).
Although present on the opposite nucleosome faces, ubiquitin was not modeled on the nucleosome face not bound by Dot1L due to poorly resolved density. In our model, Dot1L anchors to the nucleosome on the edge of the nucleosome acidic patch -an emerging hot spot for nucleosome binding ( Figure 1D ). We do not observe density for the lysine rich region C-terminal to the catalytic domain, suggesting that it binds to the nucleosome in a heterogeneous manner. In fact, no density is unaccounted for by the model in this region or any other region of the map. Ubiquitin, which is covalently attached to H2BK120, occupies a position lifted off the nucleosome surface and packs against the nucleosome-binding region of Dot1L. Interestingly, Dot1L does not engage the nucleosome surface surrounding the targeted H3K79 residue. Rather, a gap exists between H3K79 and the Dot1L active site. Because we do not observe obvious density for the S-adenosylmethionine (SAM) cofactor in the Dot1L active site, we aligned our model with a Dot1L-SAM co-crystal structure, allowing us to determine the position of SAM. This alignment shows an 18 Å distance between the donor methyl carbon of SAM and the H3K79 Cα atom ( Figure 1E ). We hypothesize that our model represents a poised state and that conformational rearrangement of the nucleosome and/or reorientation of Dot1L relative to the nucleosome is required for catalysis to occur. Interestingly, mass spectrometric analysis of our reconstituted Dot1L cat -H2BK120ub(DCA) complex shows that the majority of H3 is monomethylated ( Figure S1 ). As we did not supplement our complex with SAM, this observation suggests that Dot1L cat purified with SAM bound and has subsequently methylated the nucleosome. Therefore, the majority of our reconstructed particles contain a bound Dot1L cat that is poised for H3K79 dimethylation.
It is worth noting that the poised conformation of Dot1L in our cryo-EM model is similar to a molecular replacement model of a non-glutaraldehyde crosslinked, Dot1L-H2BK120ub nucleosome complex that we solved using an 8 Å resolution X-ray diffraction dataset (Dot1L Cα RMSD = 10.4 Å following alignment by histones) ( Figure   S3 and Table S1 ). This crystal structure shows a 2:1 Dot1L-H2BK120ub nucleosome complex in which Dot1L is bound to the identical surface of the nucleosome in a nearly identical manner, but held even farther away from H3K79 than in our cryo-EM model. We initially considered this poised conformation in our crystallographic model to be an artifact of crystal packing due to the presence of a symmetry-related copy of Dot1L wedged between the Dot1L catalytic site and its targeted nucleosome. However, the convergence of our models generated by cryo-EM and X-ray crystallography suggests a functional role for the observed conformation. Moreover, as our crystallographic complex was not glutaraldehyde crosslinked, it is unlikely that crosslinking has artificially forced Dot1L into the poised state observed in our cryo-EM structure. As the majority of particles in our cryo-EM dataset are classified into 3D classes with visible density for Dot1L in the poised conformation, we expect that this is the preferred equilibrium position of Dot1L on the nucleosome.
Significant variation of resolution exists across the reconstructed cryo-EM map ( Figure S4 ). The nucleosome dominates particle alignments and is thus well-resolved allowing high confidence modeling of most histone side chains. Even though we initiated nucleosome modeling with a high resolution nucleosome crystal structure, the final model closely resembles a published cryo-EM structure of an unbound nucleosome (RMSD = 1.2 Å across shared Cα atoms), which diverges from crystal structures most notably in the slight splaying of the H2B αC helices away from the nucleosome surface (Bilokapic et al., 2018) . In contrast to the nucleosome volume, the regions of the reconstructed map corresponding to Dot1L and ubiquitin exhibit more limited high resolution features. The catalytic domain of Dot1L was easily docked using a wellresolved nucleosome binding loop and surrounding features including the αK helix that closely borders the ubiquitin density. Secondary structure in nearby Dot1L regions including the catalytic site also aligns well to the map, but local resolution is limited due to the aforementioned conformational heterogeneity. More distant regions and large loops of Dot1L are less well resolved in our map. Ubiquitin was most challenging to model due to its smaller size and spheroidal shape. To improve rigid body docking of the ubiquitin structure, we masked the volumes of Dot1L and ubiquitin and continued refinement ( Figure S5 ). While this approach failed to generate side chain resolution for Dot1L or ubiquitin, clear density for secondary structure elements allowed high confidence docking of ubiquitin and further confirmed Dot1L placement in the nucleosome binding and active site regions.
Dot1L-nucleosome interaction
The catalytic domain of Dot1L binds to the nucleosome using a long pre-structured loop between Dot1L β9 and β10 sheets ( Figure 2A ). We clearly resolve main chain and select side chain density for this Dot1L nucleosome-interaction loop. The most striking feature within the loop is the Dot1L Arg282 side chain that clearly inserts into a cavity at the edge of the nucleosome acidic patch, in position to make a salt bridge and a hydrogen bond with the side chains of H2AE56 and H2BQ47, respectively. Two other residues in the loop, Arg278 and Asn280, are positioned to make direct nucleosome interactions, but their side chains are not clearly resolved in the map. To validate the importance of the nucleosome-interaction loop for Dot1L methyltransferase activity, we tested alanine mutants of key loop residues using an enzyme-coupled methyltransferase assay. We first established that the assay could detect Dot1L cat activity on unmodified nucleosomes and nucleosomes containing a near-native semisynthetic H2BK120ub analog with a Gly76Ala mutation in ubiquitin and that the time points and enzyme concentrations we used were in the linear range of the assay ( Figure 2B and Figure S1 ). We observe a ~6fold enhancement of Dot1L cat activity on H2BK120ub nucleosomes as compared to unmodified nucleosomes. This is a smaller enhancement than previously described using a direct assay with 3 H-SAM and may result from intrinsic differences between the assays, but the same overall trend is observed (McGinty et al., 2009) . Because Dot1L activity could be detected on both ubiquitylated and unmodified nucleosomes, we were able to assess ubiquitin-dependent and independent effects of Dot1L mutations. As predicted by our model, Dot1 Arg282Ala leads to a 90% reduction in H3K79 methylation on ubiquitylated nucleosomes and nearly abolishes all activity on unmodified nucleosomes.
Asn280Ala and Arg278Ala mutations also result in losses of activity, especially on unmodified nucleosomes, although to a lesser degree than the Arg282Ala mutant Dot1L.
Notably, the best resolved side chain in Dot1L at the nucleosome interface in our cryo-EM map is also the most important side chain for Dot1L activity regardless of H2B ubiquitylation. The Dot1L nucleosome interaction loop is well conserved in higher eukaryotes but divergent in S. cerevisiae ortholog Dot1p, leaving open the possibility that Dot1p binds nucleosomes and is activated by ubiquitin through a distinct mechanism compared to human Dot1L ( Figure 2C ).
While our structure shows that Dot1L binds to the acidic patch of ubiquitylated nucleosomes, an alternative binding mode has been suggested for Dot1L on unmodified nucleosomes (Zhou et al., 2016) . To test whether Dot1L requires the acidic patch for activity on unmodified nucleosomes, we performed competitive methyltransferase assays by titrating a GST-fusion of the nucleosome acidic patch-binding 23 amino acid LANA (latency-associated nuclear antigen from Kaposi's sarcoma-associated herpesvirus) sequence into our assays ( Figure 2D ). Wild-type LANA, but not a nucleosome bindingdeficient mutant (residues 8-10, LRS, mutated to AAA), is able to inhibit Dot1L activity on unmodified nucleosomes in a dose dependent manner. While not ruling out alternative binding modes, this suggests that Dot1L activity on ubiquitylated and unmodified nucleosomes shares a similar acidic patch interaction dependence. To our surprise, LANA fails to substantially inhibit Dot1L enzymatic activity on ubiquitylated nucleosomes even at very high concentrations ( Figure 2D ). This is not due to the GSTfusion, as pre-assay cleavage of the GST tag leads to identical results ( Figure S6 ). This observation could be secondary to tighter Dot1L binding to H2BK120ub nucleosomes or the inability of LANA to bind to H2BK120ub nucleosomes altogether. Further investigation shows that GST-LANA forms a stable complex with unmodified nucleosomes, but is unable to bind to H2BK120ub nucleosomes ( Figure S6 ). Importantly, this presents a mechanism in which H2BK120 ubiquitylation may activate Dot1L in isolation, but may also further promote Dot1L activity in cells by acting as a gatekeeper to the acidic patch and neutralizing competition for nucleosome acidic patch binding.
Dot1L-ubiquitin interaction
Ubiquitin occupies a position lifted off the nucleosome surface and rests against the αK helix of Dot1L that scaffolds the structure of the Dot1L nucleosome-interaction loop.
Dot1L and ubiquitin exhibit conformational flexibility in our cryo-EM dataset. However, docking of Dot1L and ubiquitin into finely parsed 3D classes followed by alignment by Dot1L shows that Dot1L and ubiquitin move as a unit, suggesting a direct interaction ( Figure S7 ). Previously reported comprehensive mutagenesis of the ubiquitin surface identified only two ubiquitin side chains necessary for Dot1L activation, Leu71 and Leu73, both located near the C-terminus of ubiquitin. Therefore, even though the ubiquitin-Dot1L interface appears large, we expected to find that only the small region of Dot1L adjacent to ubiquitin Leu71 and Leu73 would be responsible for ubiquitindependent activity. While the ubiquitin Leu71 side chain is poorly resolved in our map, Leu71 is at the end of the β4 strand that is part of the globular-fold of ubiquitin, so we can confidently place its side chain in proximity to Dot1L αK residues Leu322 and Phe326 ( Figure 3A) . We have less confidence in the location of ubiquitin Leu73 in our model as it resides in the flexible ubiquitin tail. However, based on its importance for ubiquitin-dependent Dot1L activity, we hypothesized that Leu73 makes direct contact with a hydrophobic surface on Dot1L. A likely surface is the exposed Ile290 side chain of Dot1L. We tested the effects of alanine mutations of Ile290, Leu322, and Phe326, as well as Glu323 and Lys330 that are also positioned at the Dot1L-ubiquitin interface but more distant from ubiquitin Leu71 and Leu73 ( Figure 3B ). To assess H2BK120ub-specific effects, we compared fold-increases in Dot1L activity due to H2B ubiquitylation for each of the Dot1L mutants. The Phe326Ala mutation effectively abolished all ubiquitindependent activity of Dot1L, with a calculated H2BK120ub fold-increase of 0.9 (compared to 6.2 for wild-type Dot1L). An Ile290Ala mutation also preferentially disrupted H2BK120-depedendent activity of Dot1L, with a calculated fold-increase of 2.8. A Dot1L Leu322Ala mutant methylated both unmodified and ubiquitylated nucleosomes with near wild-type activity, so we prepared a more severe Leu322Glu mutant Dot1L. This mutation resulted in a more pronounced reduction in activity on H2BK120ub nucleosomes than unmodified nucleosomes, leading to a ubiquitin foldincrease of 1.3. Glu323Ala and Lys330Ala mutations, which are not in the vicinity of ubiquitin Leu71 or Leu73 in our model, had minimal effects on Dot1L enzymatic activity on both nucleosomes, consistent with the published ubiquitin mutagenesis studies that found no other region of the ubiquitin surface to be necessary for Dot1L activation.
Taken together, these results suggest that Dot1L Ile290, Leu322, and Phe326 interactions with ubiquitin are critical to ubiquitin-dependent activity. Similar to the nucleosomeinteraction loop, sequences from Dot1L orthologs in higher eukaryotes align well with human Dot1L for positions at the ubiquitin interface ( Figure 3C ).
Dot1L active state model
We believe our structure represents a poised conformation of Dot1L on the nucleosome.
Our biochemical analysis shows that key interactions observed in the poised state are also required for activity and are thus likely to interact during catalysis. Therefore, we modeled the active state of the Dot1L-H2BK120ub complex by fixing the position of the Dot1L Arg282 Cα and rotating Dot1L toward H3K79 on the nucleosome surface ( Figure   4 ). As no non-SET domain methyltransferase structures exist in complex with a cofactor and a lysine-containing substrate, we used the distance between the SAH cofactor and the target lysine Cα in a ternary complex of the SET-domain containing SET8 methyltransferase to guide active state modeling (Couture et al., 2005 ). This SET8 structure shows an 8.8 Å distance between the Cα of the target lysine and the sulfur atom of the cofactor. A 17° rotation of Dot1L about Arg282 was required to replicate this distance in the Dot1L-nucleosome complex while placing the Cα of H3K79 at the entrance to the putative Dot1L substrate channel. This active state results in only minor steric clashes between Dot1L flexible loops and the nucleosome surface. Future structural characterization of an active complex will illuminate further molecular details.
Discussion
We used cryo-EM to solve the structure of Dot1L bound to an H2BK120ub nucleosome in a poised state. In our structure, Dot1L binds to the nucleosome acidic patch using a nucleosome-interaction loop. The acidic patch is emerging as a hot-spot for nucleosome binding (Kalashnikova et al., 2013; . Examination of structures of proteins and peptides bound to the nucleosome show that a common feature is the use of two arginines to bind to several locations within the acidic patch ( Figure S8 ). The first example was observed in a crystal structure of the LANA sequence bound to the nucleosome (Barbera et al., 2006) . In this structure, LANA Arg9 inserts into a cavity surrounded by H2AE61, D90, and E92 side chains. Other structures, including those with RCC1, Sir3, 53BP1, RING1B, and CENP-C, have demonstrated that many more proteins use arginines with nearly identical conformations to bind in this same acidic patch cavity, leading to the introduction of the term arginine anchor (Armache et al., 2011; Kato et al., 2013; Makde et al., 2010; McGinty et al., 2014; Wilson et al., 2016) . All of these proteins also engage the nucleosome with one or more additional arginines that bind to the acidic patch in other locations. Other structures, including our Dot1L-nucleosome structure presented here and a structure of the SAGA deubiquitinating (DUB) module , have nucleosome interactions with multiple arginines and no binding in the H2AE61/D90/E92 cavity. In general, the arginines that bind these other acidic patch surfaces exhibit more diversity in both binding sites and arginine side chain conformations than those that bind to the H2AE61/D90/E92 cavity. We suggest the use of the terms canonical arginine anchor and variant arginine anchor to describe these two classes of arginines. The Dot1L variant arginine anchor Arg282 most closely resembles the CENP-C variant arginine anchor Arg714. While we do not observe density for Dot1L
Arg278 in our cryo-EM map, the position of its Cα atom is similar to that of the LANA variant arginine anchor Arg12. Overall, the analysis of diverse acidic patch binding proteins demonstrates both shared and protein-specific molecular mechanisms for nucleosome binding in this region.
Interestingly, we found that the LANA sequence is unable to bind to H2BK120ub nucleosomes under conditions where binding to unmodified nucleosomes was observed.
This suggests that in addition to promoting Dot1L activity in a purified system, H2BK120ub may also prevent other proteins from binding the nucleosome in a physiologic cellular environment. This would limit competition, further promoting intranucleosomal methylation and may also increase local concentrations of Dot1L in areas of the nucleus containing H2BK120ub-modified chromatin. Macromolecular crystals of H2BK120ub nucleosomes do not alter the nucleosome structure and lack density for ubiquitin, suggesting ubiquitin has conformational flexibility in the absence of other bound factors (Machida et al., 2016) . Therefore, it is unlikely that ubiquitin competes with LANA by binding directly to the acidic patch. Rather we favor the explanation that a conformationally flexible ubiquitin in the vicinity of the acidic patch can prevent acidic patch binding of other proteins. Some proteins for which H2BK120ub inhibits chromatin binding may have been identified in nucleosome affinity proteomics experiments with ubiquitylated nucleosomes, including RCC1, another acidic patch binder (Shema-Yaacoby et al., 2013) . H2BK120ub is one of many acidic patch proximal histone modifications, and several of these modifications also tune the nucleosome binding and/or activity of chromatin effector proteins (Dann et al., 2017; Fujiki et al., 2011; Jbara et al., 2016) . Given the emerging trend of acidic patch-dependent chromatin binding, this is likely to be a major mechanism in the regulation of chromatin processes.
In our structure, ubiquitin is lifted off the nucleosome surface and is in a position to interact with the catalytic domain of Dot1L. Computational sorting of particles with different conformational states of Dot1L with respect to the nucleosome demonstrates that Dot1L and ubiquitin move together through a continuum of positions. We also identify mutants in Dot1L that preferentially disrupt activity on H2BK120ub nucleosomes over unmodified nucleosomes. Taken together, our data suggest that ubiquitin enhances Dot1L activity through direct interactions with the catalytic domain of Dot1L. Contrary to this model, photocrosslinking studies place ubiquitin Leu71 and Leu73 in proximity to the H2A N-terminal tail (Zhou et al., 2016) . We have not observed any density for ubiquitin near the emergence of the H2A tail from the nucleosome disk or for the first 15 residues of the H2A tail either interacting with ubiquitin or other parts of the complex. As our cryo-EM map predicts conformational flexibility in ubiquitin, we anticipate that crosslinking to H2A may occur only in minor ubiquitin conformations.
Previous results show that moving ubiquitin from H2BK120 to H2BK125 leads to a modest decrease in Dot1L activity, while moving ubiquitin to H2BK116 or K108 dramatically or entirely inhibits Dot1L, respectively (Supplementa1 Figure S9 ) (Chatterjee et al., 2010) . While we do not see clear density for the ubiquitin-H2BK120 linkage in our cryo-EM map, we hypothesize that the ubiquitin C-terminal tail is flexible enough to allow ubiquitin to reach its observed position in our structure from an H2BK125 attachment site. However, H2BK108 and H2BK116 attachment places ubiquitin between Dot1L and the nucleosome and likely prevents productive binding of Dot1L as a result. We generated a model of Dot1L in an active conformation on the nucleosome surface. This model largely accommodates Dot1L loops without structural rearrangements. It has been demonstrated that a basic sequence in the H4 N-terminal tail is critical for Dot1L activity (Fingerman et al., 2007; McGinty et al., 2009 ). In our model, there is an acidic cleft on the surface of Dot1L adjacent to the location from which the H4 N-terminal tail emerges from the nucleosome. We hypothesize that the H4 basic patch binds to this Dot1L acidic cleft to promote formation of a catalytically active conformation of Dot1L on the nucleosome.
In summary, we solved the cryo-EM structure of Dot1L bound to an H2BK120ub nucleosome. Dot1L binds to the nucleosome acidic patch using a nucleosome-interaction loop and interacts directly with ubiquitin for activation. Dot1L-mediated methylation of H3K79 is essential to the pathogenesis of MLL-rearranged leukemias, prompting the development of Dot1L inhibitors that are now in clinical trials. Our structure and subsequent biochemical validation identify mutations to interrogate the nucleosomespecific and ubiquitin-dependent functions of Dot1L. This will enable precision hypothesis-driven analysis of the functions of Dot1L in normal and leukemia model cells.
Further, our studies suggest that H2BK120 ubiquitylation may function as a gatekeeper of the acidic patch. The tuning of acidic patch binding by adjacent post-translational modifications is likely to be a fundamental mechanism in the regulation of chromatin signaling. inactivating mutant was a gift from Song Tan. This inactive ExoX was expressed and purified as described above for Dot1L cat . TEV cleavage leaves a 3x Gly-Ser sequence at the N-terminus of ExoX.
Materials and Methods
Preparation of proteins and nucleosomes
Recombinant Xenopus and human histones were expressed, purified and reconstituted into nucleosomes as previously described (Luger et al., 1999) . Nucleosomes were assembled with 147 or 155 bp of the 601 DNA sequence (Lowary and Widom, 1998) with the nucleosome positioning sequence centered in each DNA fragment.
H2BK120ub(DCA) was prepared essentially as previously described . Briefly, Xenopus H2BK120C was cloned by site-directed mutagenesis and the pST50Tr-STR-His 10 -ubiquitin (Gly76Cys) Mass spectrometric characterization was preformed using an Agilent 6520 Accurate Mass Quadrupole Time-of-Flight mass spectrometer. H2BK120ub analogs were assembled into nucleosomes as described above.
Reconstitution of Dot1L cat -H2BK120ub nucleosome complex
The Dot1L chaperone. Reconstitution of the complex was performed as described above, with the following changes: 1) 2.5 molar equivalents of ExoX was added in four steps after addition of Dot1L and 2) reconstitution and purification were performed in reconstitution buffer containing 50 mM NaCl.
Cryo-EM sample preparation
Dot1L cat -H2BK120ub(DCA) nucleosome complex at ~10 mg/ml was buffer exchanged into crosslinking buffer (10 mM HEPES pH 7.5, 150 mM NaCl) using a Zeba spin desalting column (Thermo Fisher). Glutaraldehyde (Sigma Aldrich) was added to a final concentration of 0.1% and crosslinking was allowed to proceed for 5 min at room temperature. Glutaraldehyde was quenched by the addition of Tris-Cl at pH 7.5 to a final concentration of 20 mM. After 15 min at room temperature, samples were buffer exchanged into crosslinking buffer. Complex was diluted to 0.93 mg/ml in freezing buffer (10 mM HEPES pH 7.5, 48 mM NaCl) prior to spotting on a Quantifoil R1.2/1.3, 300 mesh grid for vitrification after blotting for 4 s using a Vitrobot Mark IV (FEI) cryoplunger at 100% humidity and 4°C. An identical complex was analyzed by liquid chromatography coupled mass spectrometry using an Agilent 6520 Accurate Mass Quadrupole Time-of-Flight mass spectrometer to assess the methylation state of histone H3.
Cryo-EM data collection and analysis
Cryo-EM data was collected on a Titan Krios (FEI) operating at 300 kV. The images were recorded using the automated data acquisition software EPU (FEI) using a Falcon III direct electron detector (FEI) operated in electron counting mode at a nominal magnification of 75,000, corresponding to a pixel size of 1.08 Å, and at a defocus range of -1.25 µm to -2.75 µm. Each exposure lasted 60 s and was collected as a 30-frame movie at a dose rate of ~0.8e -/pix/s, resulting in a total electron dose of ~42 e -/Å 2 . Wholeframe movie alignment was performed with MotionCor2 (Zheng et al., 2017) , CTF parameters were estimated with GCTF (Zhang, 2016) , and Relion v2.1 (Kimanius et al., 2016) was used for subsequent data analysis. Initially, ~1,000 particles were manually picked to generate 2D class averages to use as templates for iterative rounds of automatic particle picking. In total, 408,526 automatically selected particles were subjected to reference-free 2D classification. Iterative rounds of 2D classification were used to narrow the set to 156,709 high quality particles. 3D classification using a 50 Å low pass filtered nucleosome structure (PDBID 6ESF) generated in Relion as reference identified two classes (3 and 4) containing clearly defined Dot1L-nucleosome complexes. Movie into the 3.9 Å reconstructed map using Chimera (Pettersen et al., 2004) and refined by iterative real-space refinement in Phenix (Afonine et al., 2018) and manual model building in Coot (Emsley et al., 2010) . Local resolution was calculated with ResMap (Kucukelbir et al., 2014) . Resolution of reconstructions was calculated using the gold standard FSC criterion of 0.143. All molecular graphics were prepared with Chimera.
Crystallization and X-ray crystallography
The Dot1L cat -ExoX-H2BK120ub(DCA) nucleosome complex was concentrated to 10 mg/ml and crystallized by mixing 1:1 with 25 mM Bis-Tris pH 6 (Hampton), 25 mM (NH 4 ) 2 HPO 4 (Hampton), and 1.5% PEG2000-MME (Fluka) at room temperature using modified microbatch under oil with Al's oil (D'Arcy et al., 2004) . Notably, this complex was not crosslinked with glutaraldehyde. Inactive ExoX was used as a crystallization chaperone (Robert McGinty and Song Tan unpublished results) . Crystals were collected after 20-35 days and dehydrated and cryoprotected by soaking at room temperature in 25 mM Bis-Tris pH 6, 25 mM (NH 4 ) 2 HPO 4 , and 3.75% PEG2000-MME in drops containing increasing concentrations of PEG400 (final concentration 24%, increment 4%, soak interval 15 min). Upon completion of soaking, crystals were flash cooled in liquid nitrogen. Diffraction data was collected on the Advanced Photon Source SER-CAT 22-ID beamline at 1 Å and 100 K. Data was processed using HKL2000 (Otwinowski and Minor, 1997) in the C2221 space group. A molecular replacement model was generated with CCP4 Phaser MR (McCoy et al., 2007) using a polyalanine half nucleosome model generated from PDBID 1KX5 and a polyalanine Dot1L catalytic domain model generated from PDBID 1NW3, with loop residues 296-313 deleted.
Lysine methyltransferase assays
Lysine methyltransferase assays were performed using the MTase-Glo enzymemethyltransferase kit (Promega) using the manufacturer's protocol. Briefly, 1 µM nucleosomes were combined with 15 nM wild-type or mutant Dot1L cat in methyltransferase buffer (20 mM Tris-Cl pH 8.0, 50 mM NaCl, 1 mM EDTA, 0.1 mg/ml BSA, 1 mM DTT, and 20 µM SAM) in a total volume of 8 µl. The concentration of 15 nM Dot1L was selected as it was very close to the linear range of activity on H2BK120ub nucleosomes, while allowing activity on unmodified nucleosomes to be measured robustly. Using the same concentration allowed the direct comparison of activity on ubiquitylated and unmodified nucleosomes. The assay was allowed to proceed at 30°C for 30 min prior to developing the assay and quantifying luminescence using an Envision 2103 Multilabel plate reader (Perkin Elmer). Assays were performed with 5 replicates.
All assays were performed with human histones except for Xenopus unmodified or ubiquitylated H2B. No significant difference in Dot1L activity was observed between nucleosomes containing Xenopus H2B and those containing canonical human H2B, validating the use of chimeric nucleosomes. For LANA competition methyltransferase activity assays, AVT-GST-His 6 -LANA or AVT-GST-His 6 -LANA(LRS>AAA) were added to the assay at 0, 5, 10, 25, 50, and 100 µM final concentrations. An additional assay was performed after incubation of LANA fusion proteins with 0.025 molar equivalents of TEV protease overnight at room temperature. Cleavage of LANA affinity tags was verified by SDS-PAGE.
Gel filtration-based binding assay
AVT-GST-His 6 -LANA was reconstituted with H2BK120ub(Gly76Ala) or unmodified nucleosomes as described above for Dot1L-nucleosome reconstitutions at a 4:1 molar ratio (~4.5 µM nucleosome) in 10 mM Tris-Cl pH 8.0, 50 mM NaCl, and 1 mM DTT.
Interaction was evaluated by separation on a Superdex 200 increase gel filtration column equilibrated in the same buffer. Chromatography fractions were analyzed by SDS-PAGE. Figure S10. Mass spectrometry characterization of Dot1L mutant proteins. ESImass spectra of (left) and deconvoluted mass spectra (right) for mutant Dot1L proteins.
